Full Text
The Rise of Orphan Drugs In Europe Vs The United States- Comparing Orphan Drug Designations Between The Ema And Fda

Abstract

Authors

M Mildred S Lee

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×